Search Within


表示中 1-6 of 6 結果 for "C1562" within 文献
Helen A Fletcher et al.
Vaccine, 26(41), 5269-5275 (2008-08-07)
In clinical trials recombinant-modified vaccinia virus Ankara expressing the Mycobacterium tuberculosis antigen 85A (MVA85A) induces approximately 10 times more effector T cells than any other recombinant MVA vaccine. We have found that in BCG primed subjects MVA85A vaccination reduces transforming
Robert Herzog et al.
Molecular genetics and genomics : MGG, 294(3), 663-677 (2019-02-20)
Agrocybe aegerita is a cultivated edible mushroom in numerous countries, which also serves as a model basidiomycete to study fruiting body formation. Aiming to create an easily expandable customised molecular toolset for transformation and constitutive gene of interest expression, we
Vanessa Cristina de Oliveira et al.
PloS one, 15(7), e0235856-e0235856 (2020-07-11)
Gene editing in large animal models for future applications in translational medicine and food production must be deeply investigated for an increase of knowledge. The mitochondrial transcription factor A (TFAM) is a member of the HMGB subfamily that binds to
Arend F van Peer et al.
Applied and environmental microbiology, 75(5), 1243-1247 (2008-12-31)
Phleomycin is mutagenic by introducing double-strand breaks in DNA. The ble gene of Streptoalloteychus hindustanus, which confers resistance to this substance, is widely used as a selection marker for transformation. Schizophyllum commune grows on 25 microg of phleomycin ml(-1) after
Ji-Suk Cho et al.
Applied microbiology and biotechnology, 73(6), 1470-1476 (2006-10-06)
Transgenic suspension cells of Oryza sativa L. cv. Dongjin utilized as a host for producing recombinant human cytotoxic T-lymphocyte antigen 4-immunoglobulin (hCTLA4Ig) were preserved in liquid nitrogen (-196 degrees C) after slow prefreezing in a deep freezer (-70 degrees C).
Lise M van Wijk et al.
Cancers, 12(10) (2020-10-03)
Recent studies have shown that the efficacy of PARP inhibitors in epithelial ovarian carcinoma (EOC) is related to tumor-specific defects in homologous recombination (HR) and extends beyond BRCA1/2 deficient EOC. A robust method with which to identify HR-deficient (HRD) carcinomas
1 / 1 ページ